Low albumin levels in oncologic disease might be secondary to the intense systemic inflammatory response syndrome, which requires an increased synthesis of acute-phase proteins, reducing the synthesis of other proteins, such as albumin. The gene discussed is ALB; the disease is systemic inflammatory response syndrome.